Abstract
Systems biology promises to describe and model complete biological systems quantitatively. Recently, in many areas of biological research, focus has shifted from detailed characterization of an individual gene or gene function in terms of its effect on a cellular process (the reductionist approach) to understanding the behavior of networks of genes or gene products from a genome-wide perspective (the systems biology approach). Here we review how analyses that allowed genome-wide investigations (by mining and integrating data from various “omics”) have contributed to our understanding of biological processes from genes to networks. We will discuss these advances in terms of quantitative leaps in which the scope of a known process was only revealed by genome studies (e.g., fraction of genes with alternative transcription start sites, splicing isoforms, or protein isoforms) and qualitative leaps in which completely new phenomena have been revealed (e.g., dark matter in the genome, functional pseudogenes, scale-free protein networks, fluidity of microbial genomes, and the diversity of the microbiome). We will discuss what the future holds for systems biology in terms of unrealized leaps that may provide new surprises from the viewpoints of academic and biomedical research.
Current Proteomics
Title: Systems Biology: Understanding Function from Genes to Networks
Volume: 6 Issue: 2
Author(s): Ravinder Singh and Rob Knight
Affiliation:
Abstract: Systems biology promises to describe and model complete biological systems quantitatively. Recently, in many areas of biological research, focus has shifted from detailed characterization of an individual gene or gene function in terms of its effect on a cellular process (the reductionist approach) to understanding the behavior of networks of genes or gene products from a genome-wide perspective (the systems biology approach). Here we review how analyses that allowed genome-wide investigations (by mining and integrating data from various “omics”) have contributed to our understanding of biological processes from genes to networks. We will discuss these advances in terms of quantitative leaps in which the scope of a known process was only revealed by genome studies (e.g., fraction of genes with alternative transcription start sites, splicing isoforms, or protein isoforms) and qualitative leaps in which completely new phenomena have been revealed (e.g., dark matter in the genome, functional pseudogenes, scale-free protein networks, fluidity of microbial genomes, and the diversity of the microbiome). We will discuss what the future holds for systems biology in terms of unrealized leaps that may provide new surprises from the viewpoints of academic and biomedical research.
Export Options
About this article
Cite this article as:
Singh Ravinder and Knight Rob, Systems Biology: Understanding Function from Genes to Networks, Current Proteomics 2009; 6 (2) . https://dx.doi.org/10.2174/157016409788680974
DOI https://dx.doi.org/10.2174/157016409788680974 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biophysical Modeling and Associated Signal Modeling in Functional Magnetic Resonance Imaging
Neuroscience and Biomedical Engineering (Discontinued) Evaluation of Antidiabetic Activity of <i>Rosmarinus officinalis var. prostratus</i> Growing in Syria in Alloxan Diabetic Rats
Current Bioactive Compounds Anti-Invasive and Anti-Metastasis Strategies: New Roads, New Tools and New Hopes
Current Cancer Drug Targets Cognitive, Psychological and Psychiatric Effects of Ionizing Radiation Exposure
Current Medicinal Chemistry The Digenea Parasite Opisthorchis felineus: A Target for the Discovery and Development of Novel Drugs
Infectious Disorders - Drug Targets Phenazine 5,10-Dioxide Derivatives as Hypoxic Selective Cytotoxins: Part II. Structure-Activity Relationship Studies
Medicinal Chemistry Recent Medicinal Chemistry Approach for the Development of Dipeptidyl Peptidase IV Inhibitors
Current Medicinal Chemistry Diabetic Retinopathy: Current and New Treatment Options
Current Diabetes Reviews Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology
Recent Patents on Anti-Cancer Drug Discovery Advances in Parallel Screening of Drug Candidates
Current Medicinal Chemistry Targeted Cancer Therapeutics: Biosynthetic and Energetic Pathways Characterized by Metabolomics and the Interplay with Key Cancer Regulatory Factors
Current Pharmaceutical Design Disintegrins
Current Drug Targets - Cardiovascular & Hematological Disorders Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Efficacy of Yun Zhi (Coriolus versicolor) on Survival in Cancer Patients: Systematic Review and Meta-Analysis
Recent Patents on Inflammation & Allergy Drug Discovery Progress and Prospects: The Use of 3D Spheroid Model as a Relevant Way to Study and Optimize DNA Electrotransfer
Current Gene Therapy Anticancer Drug Development, System Updating and Global Participations
Current Drug Therapy Structure and Antioxidant Catalytic Function of Plant Glutathione Transferases
Current Chemical Biology Delivery Systems for Applications in siRNA Technology
Drug Delivery Letters Induced Pluripotent Stem Cells as a Model for Accelerated Patient- and Disease-specific Drug Discovery
Current Medicinal Chemistry Pituitary Stem Cells Drop Their Mask
Current Stem Cell Research & Therapy